Lack of somatic alterations of MC1R in primary melanoma

Pigment Cell and Melanoma Research

Volumn 21, Issue 5, 2008, Pages 579-582

  Kim, R D ^a   Curtin, J A ^a,b   Bastian, Boris C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Alterations; MC1R; Melanocortin 1 receptor gene; Melanoma; Somatic mutations

Indexed keywords

B RAF KINASE; MELANOCORTIN 1 RECEPTOR PROTEIN; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MUCOSA; SKIN DEFECT; SKIN PIGMENTATION; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MELANOMA; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; RECEPTOR, MELANOCORTIN, TYPE 1; SKIN NEOPLASMS; SKIN PIGMENTATION;

SOLEIDAE;

EID: 52149083714     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2008.00497.x     Document Type: Article

References (18)

1. Beaumont, K.A., Shekar, S.N., Newton, R.A., James, M.R., Stow, J.L., Duffy, D.L. Sturm, R.A. (2007). Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum. Mol. Genet. 16, 2249 2260. E-pub 5 July 2007.
2. Bohm, M., Wolff, I., Scholzen, T.E., Robinson, S.J., Healy, E., Luger, T.A., Schwarz, T. Schwarz, A. (2005). alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J. Biol. Chem. 280, 5795 5802. E-pub 29 November 2004.
3. Chakraborty, A.K., Funasaka, Y., Slominski, A., Ermak, G., Hwang, J., Pawelek, J.M. Ichihashi, M. (1996). Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim. Biophys. Acta 1313, 130 138.
4. Chhajlani, V. Wikberg, J.E. (1992). Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309, 417 420.
5. Curtin, J.A., Fridlyand, J., Kageshita, T. et al. (2005). Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353, 2135 2147.
6. Curtin, J.A., Busam, K., Pinkel, D. Bastian, B.C. (2006). Somatic activation of KIT in distinct subtypes of melanoma. J. Clin. Oncol. 24, 4340 4346.
7. Healy, E., Todd, C., Jackson, I.J., Birch-Machin, M. Rees, J.L. (1999). Skin type, melanoma, and melanocortin 1 receptor variants. J. Invest. Dermatol. 112, 512 513.
8. Kadekaro, A.L., Kavanagh, R., Kanto, H. et al. (2005). alpha-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res. 65, 4292 4299.
9. Kennedy, C., ter Huurne, J., Berkhout, M., Gruis, N., Bastiaens, M., Bergman, W., Willemze, R. Bavinck, J.N. (2001). Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J. Invest. Dermatol. 117, 294 300.
10. Landi, M.T., Bauer, J., Pfeiffer, R.M., Elder, D.E., Hulley, B., Minghetti, P., Calista, D., Kanetsky, P.A., Pinkel, D. Bastian, B.C. (2006). MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313, 521 522.
11. Maldonado, J.L., Fridlyand, J., Patel, H. et al. (2003). Determinants of BRAF mutations in primary melanomas. J. Natl Cancer Inst. 95, 1878 1880.
12. Naysmith, L., Waterston, K., Ha, T., Flanagan, N., Bisset, Y., Ray, A., Wakamatsu, K., Ito, S. Rees, J.L. (2004). Quantitative measures of the effect of the melanocortin 1 receptor on human pigmentary status. J. Invest. Dermatol. 122, 423 428.
13. Palmer, J.S., Duffy, D.L., Box, N.F., Aitken, J.F., O'Gorman, L.E., Green, A.C., Hayward, N.K., Martin, N.G. Sturm, R.A. (2000). Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 66, 176 186.
14. Rees, J.L. (2004). The genetics of sun sensitivity in humans. Am. J. Hum. Genet. 75, 739 751. E-pub 15 September 2004 (Review).
15. Rees, J.L. Healy, E. (1997). Melanocortin receptors, red hair, and skin cancer. J. Invest. Dermatol. Suppl. Proc. 2, 94 98.
16. Robinson, S.J. Healy, E. (2002). Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix. Oncogene 21, 8037 8046.
17. Schauer, E., Trautinger, F., Kock, A., Schwarz, A., Bhardwaj, R., Simon, M., Ansel, J.C., Schwarz, T. Luger, T.A. (1994). Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J. Clin. Invest. 93, 2258 2262.
18. Valverde, P., Healy, E., Sikkink, S. et al. (1996). The Asp84Glu variant of the melanocrtin 1 receptor (MC1R) is associated with melanoma. Hum. Mol. Genet. 5, 1663 1666.